Navigation Links
Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival,Benefits as Mitigator Against Radiation-Induced Damage in Study

itting Protectan CBLB502 to the Department of Defense (DoD) in response to a recently published Request for Proposal (RFP) for medical radiation countermeasures to treat gastrointestinal effects of acute radiation syndrome. The RFP award would provide funding for development of the countermeasure through FDA approval, as well as a commitment to purchase up to 500,000 doses, thereafter.

Protectan CBLB502 is undergoing an accelerated development program under the FDA two-animal rule, which requires the Company to show efficacy in two animal species and only safety in humans. Cleveland BioLabs is in the process of completing Good Manufacturing Practices compliant (cGMP) manufacturing of Protectan CBLB502 and plans to submit an Investigational New Drug (IND) application for a human safety study later this year.

Cleveland BioLabs President and Chief Executive Officer, Michael Fonstein, Ph.D., added, "The radio-protective properties of Protectan CBLB502 are specific to healthy, non-cancerous tissues, making CBLB502 a promising candidate to treat side effects of cancer patients undergoing radiation therapy and potentially, chemotherapy. The National Cancer Institute reports that for every $1 spent on cancer treatments, approximately $0.70 is spent on supportive care to counteract the side effects of treatment. We believe this could be a significant potential follow-on market for CBLB502."

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. The Company has strategic partnerships with the Cleveland Clinic Foundation, Roswell Park Cancer Institute, ChemBridge Corporation and the Armed Forces Research Radiobiology Institute. To learn more about Cleveland BioLabs, Inc., please visit the company's website at http://www.cbiolabs.com.
'"/>




Page: 1 2 3

Related medicine technology :

1. Cholesterol Drug Fails to Slow Progression of Coronary Disease, Cleveland Clinic Study Reports
2. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. New Research Demonstrates Broad Efficacy of Azixa (MPC-6827) Against Multiple Tumor Types and in Drug Resistant Cell Lines
5. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
6. Gerons Telomerase Inhibitor Cancer Drug Demonstrates Good Pharmacokinetics and Tolerability in Phase I/II Trial
7. Frova Phase III Study Data Demonstrates That Short-Term Prevention Treatment Reduces Frequency and Severity of Menstrual Migraine
8. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
9. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
10. Introgens Advexin Demonstrates Clinical Benefit in Inherited Cancer
11. Prostate Cancer: Clinical Study Demonstrates Superior Efficacy of Docetaxel Chemotherapy
Post Your Comments:
(Date:5/16/2013)... May 16, 2013  PTC Therapeutics, Inc., today announced ... S-1 with the U.S. Securities and Exchange Commission ("SEC") ... common stock. The number of shares to be offered ... been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ) ... as joint book-running managers for the offering. Cowen and ...
(Date:5/16/2013)... Inc. (NYSE: ALR ), a global leader in ... through the merger of rapid diagnostics and health management, has ... Series B Convertible Perpetual Preferred Stock (NYSE: ALR.PR.B).  The dividend ... of Series B stock at the close of business on ... amount of all dividends accrued from April 1, 2013 through ...
(Date:5/16/2013)... ADDISON, Texas , May 16, 2013  ULURU Inc. ... quarter ended March 31, 2013 and provided a review of ... activities, the Company is confirming the previously communicated outlook for ... markets; , Expanding the network of distribution partners to ... and , Positioning Altrazeal ® to be marketed ...
Breaking Medicine Technology:PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
... the battle is ... far from won, ... patients with blood cancers. Sixty years ago there,were few effective treatments for ... low. Today, about 75 percent of children with,acute leukemia and nearly 80 ...
... Fla., Sept. 12 Once every two hours a,Florida ... skin cancer,according to the American Cancer Society. A local ... the likelihood that local,residents diagnosed with this deadliest type ... the sun or protecting your skin from harmful,ultraviolet rays ...
Cached Medicine Technology:September is Leukemia, Lymphoma and Myeloma Awareness Month 2Saving Lives of Florida Residents Who Develop Skin Cancer Each Year: The Key is Early Detection and Treatment 2
(Date:5/18/2013)... New York, NY (PRWEB) May 18, 2013 ... of consistent efforts, SizeItUp formally announced the integration ... The redesigned 2012 Hyundai Genesis is set to stun the ... comfort and style. 2012 Hyundai Genesis is marked as the ... database and heads the vehicles lined up for the year ...
(Date:5/18/2013)... AL (PRWEB) May 18, 2013 Although ... malignant tumors, the association between obesity and esophageal adenocarcinoma, ... for other obesity-related tumors. As reported on ... people are almost twice as likely as those of ... Although the relationship between obesity and esophageal cancer is ...
(Date:5/18/2013)... May 18, 2013 Show And Go Training, ... various different training systems that is all about is getting ... the attention of http://ShowAndGoTrainingReview.com ’s Stan Stevenson, prompting ... is a unique “four phase system” designed to make you ... of time spent working out in the gym. The training ...
(Date:5/18/2013)... Los Angeles, Ca (PRWEB) May 18, 2013 ... lot of people. But among the horde of new weight ... the one most talked about. Recent studies about this newest ... to achieve one’s ideal body shape. , Garcinia Cambogia is ... looks like a tamarind. Eating the fruit can suppress a ...
(Date:5/18/2013)... May 18, 2013 John Ravera, D.D.S., a ... addition of a new member to his dental team, Courtney ... in the field for over 10 years. She received her ... and was elected a member of Sigma Pi Alpha, a ... Marino enjoys working with patients of all ages, helping them ...
Breaking Medicine News(10 mins):Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2Health News:Lose Weight Without Dieting or Exercising with Garcinia Cambogia Select Now Available At HealthCareSupplementz.com 2Health News:Newport Beach Cosmetic Dentist John Ravera Adds New Member to Dental Team 2
... DETROIT Why are African Americans more likely than Caucasians to ... die from the disease? While the answer isn,t a simple ... in part, be to blame, according to a new study from ... are more likely to be past or current smokers, one of ...
... chronic vulvar pain (pain at the opening to the vagina) ... long periods of time, painful, if not impossible. A ... women in the metro Detroit area, found that more than ... some point in their lives. However, only two percent of ...
... State University research groups have teamed up with the ... & Manufacturing North America, Inc. (TEMA), to work on ... Safety Research Center (CSRC). The CSRC ... the safety of vehicles, drivers, passengers and pedestrians. Over ...
... a particlular gene,s link to optimism, self-esteem and "mastery," the belief ... psychological resources for coping well with stress and depression. ... years, and it is not the gene I expected," said Shelley ... author of the new research. "I knew there had to be ...
... 2011) Research conducted by Boston College neuroscientist Sean MacEvoy ... evidence of a new way of considering how the brain ... published in the latest issue of Nature Neuroscience . ... resonance image (fMRI) to help them identify how the brain ...
... , TUESDAY, Sept. 13 (HealthDay News) --,A healthy lifestyle ... of vegetables -- could ward off many cases of heart failure, ... 18,000 men and nearly 20,000 women from Finland ranging in age ... time, 638 of the men and 445 of the women developed ...
Cached Medicine News:Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 2Health News:Genetics, lifestyle provide clues to racial differences in head and neck cancer 3Health News:Chronic vulvar pain a reality for more than 100,000 women in southeast Michigan 2Health News:Wayne State University partners with Toyota on safety research 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 2Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 3Health News:UCLA psychologists discover a gene's link to optimism, self-esteem 4Health News:Researchers utilize neuroimaging to show how brain uses objects to recognize scenes 2Health News:Lifestyle Changes May Prevent Heart Failure 2
Malaria device / strip (2 line, PAN specific-pLDH)...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
High sensitive, specific one step immunochromatographic assay for human infectious disease...
Detection of antibodies to Malaria in Human whole blood....
Medicine Products: